The Specialized Medical Company (SMC) priced its Tadawul IPO at SAR 25 a pop, the top of its indicative range, after its institutional bookbuilding was 65x oversubscribed, according to a statement (pdf). This implies a total offering size of around SAR 1.9 bn and a market cap of SAR 6.3 bn at listing.

ICYMI- The private healthcare provider is taking a 30% stake to market in a secondary offering. SMC’s IPO retail subscription was pushed back to 15-16 June, with the final allocation of shares slated for Tuesday, 24 June. The company closed the institutional book for its IPO late in May, after identifying an inconsistency across financial disclosures and securing the retrieval of SAR 200 mn (USD 53 mn) in recently paid dividends.

One of the largest IPOs this year: While Flynas’ SAR 4.1 bn listing is expected to secure the title for the biggest IPO in 2025, SMC’s offering is poised to be the third-largest listing on the main market so far this year — landing between Umm Al Qura for Development’s SAR 2 bn IPO in March and Almoosa Health’s SAR 1.7 bn debut in January.

ADVISORS- Our friends at EFG Hermes are quarterbacking the transaction as joint financial advisors, underwriters, and bookrunners, alongside SNB Capital. SNB Capital is also serving as lead manager, with White & Case providing counsel to the issuer. Receiving agents include Al Rajhi Capital, BSF Capital, Alinma Investment, and Riyad Capital, among others.

ALSO IN THE PIPELINE-